3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
21
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Ovarian Neoplasms
1
Neoplasms
1
Lymphoma, Follicular
1
Genetic Predisposition to Disease
1
Generalized Anxiety Disorder
1
Fanconi Anemia, Complementation Group D1
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Anxiety Disorders
1
Interventions
Surveys and Questionnaires
86
Blood Specimen Collection
58
Interviews as Topic
28
Observation
15
Data Collection
15
Radiotherapy
12
Watchful Waiting
11
Magnetic Resonance Spectroscopy
11
Hematologic Tests
11
Exercise
11
Drug Therapy
11
Quality of Life
9
Biopsy
8
Specimen Handling
7
Therapeutics
6
Restraint, Physical
6
Magnetic Resonance Imaging
6
Focus Groups
6
pembrolizumab
5
Standard of Care
5
Rivaroxaban
5
Phlebotomy
5
Nivolumab
5
Lapatinib
5
Immune Checkpoint Inhibitors
5
atezolizumab
4
apixaban
4
Trastuzumab
4
Patient Reported Outcome Measures
4
Palliative Care
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Neoplasms
×
Cognitive Behavioral Therapy
×
Clear all
NCT03889171
2019-03-28
PSICOM
University Hospital, Montpellier
Completed
200 enrolled